N,N-DiMethyl 2-broMo-6-fluorobenzylaMine
|
- $165 - $1171
- Product name: N,N-DiMethyl 2-broMo-6-fluorobenzylaMine
- CAS: 1355247-17-4
- MF: C9H11BrFN
- MW: 232.09
- EINECS:
- MDL Number:MFCD21333061
- Synonyms:N,N-DiMethyl 2-broMo-6-fluorobenzylaMine;1-(2-bromo-6-fluorophenyl)-N,N-dimethylmethanamine;Benzenemethanamine, 2-bromo-6-fluoro-N,N-dimethyl-
5 prices
Selected condition：
Brand
- AK Scientific
- Crysdot
- TRC
- Usbiological
Package
- 100mg
- 500mg
- 5g
- 10g
- ManufacturerAK Scientific
- Product numberZ9963
- Product descriptionN,N-Dimethyl2-bromo-6-fluorobenzylamine
- Packaging10g
- Price$1171
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12151184
- Product descriptionN,N-Dimethyl2-bromo-6-fluorobenzylamine 95+%
- Packaging5g
- Price$452
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12151184
- Product descriptionN,N-Dimethyl2-bromo-6-fluorobenzylamine 95+%
- Packaging10g
- Price$790
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD456845
- Product descriptionN,N-Dimethyl2-bromo-6-fluorobenzylamine
- Packaging500mg
- Price$165
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number459859
- Product descriptionN,N-Dimethyl 2-bromo-6-fluorobenzylamine
- Packaging100mg
- Price$319
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | Z9963 | N,N-Dimethyl2-bromo-6-fluorobenzylamine | 10g | $1171 | 2021-12-16 | Buy |
| Crysdot | CD12151184 | N,N-Dimethyl2-bromo-6-fluorobenzylamine 95+% | 5g | $452 | 2021-12-16 | Buy |
| Crysdot | CD12151184 | N,N-Dimethyl2-bromo-6-fluorobenzylamine 95+% | 10g | $790 | 2021-12-16 | Buy |
| TRC | D456845 | N,N-Dimethyl2-bromo-6-fluorobenzylamine | 500mg | $165 | 2021-12-16 | Buy |
| Usbiological | 459859 | N,N-Dimethyl 2-bromo-6-fluorobenzylamine | 100mg | $319 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|